NZ600527A - Antiviral compounds - Google Patents
Antiviral compoundsInfo
- Publication number
- NZ600527A NZ600527A NZ600527A NZ60052708A NZ600527A NZ 600527 A NZ600527 A NZ 600527A NZ 600527 A NZ600527 A NZ 600527A NZ 60052708 A NZ60052708 A NZ 60052708A NZ 600527 A NZ600527 A NZ 600527A
- Authority
- NZ
- New Zealand
- Prior art keywords
- inhibitors
- compound
- hcv
- treating
- antiviral compounds
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
600527 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof of for treating a hepatitis C virus (CV). Additionally disclosed is a pharmaceutical composition comprising said compound, and optionally further comprising at least one additional therapeutic agent such as interferons, ribavirin analogs, NS3 protease inhibitors, NS5b polymerase inhibitors, alpha-glucosidase 1 inhibitors, hepatoprotectants, non-nucleoside inhibitors of HCV, and other drugs for treating HCV.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93775207P | 2007-06-29 | 2007-06-29 | |
US95969807P | 2007-07-16 | 2007-07-16 | |
NZ58209108 | 2008-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ600527A true NZ600527A (en) | 2014-01-31 |
Family
ID=50619563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ600527A NZ600527A (en) | 2007-06-29 | 2008-06-26 | Antiviral compounds |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ600527A (en) |
-
2008
- 2008-06-26 NZ NZ600527A patent/NZ600527A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL195025A (en) | Cyclopropyl fused indolobenzazepine derivatives and pharmaceutical compositions comprising the same as anti-hcv medicament | |
SV2005001920A (en) | "NUCLEOSID COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS" | |
IL207468A (en) | Hcv inhibitors and use thereof for the preparation of medicaments for treatment of hcv infections | |
WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
WO2005077969A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
EP2431379A3 (en) | HCV inhibitors | |
JP2011528713A5 (en) | ||
WO2006039488A3 (en) | Hcv ns3-ns4a protease inhibition | |
AR049635A1 (en) | (1R, 2S, 5S) -N - ((1S) -3-AMINO-1- (CYCLLOBUTILMETIL) -2,3-DIOXOPROPIL) -3 - ((2S) -2 - (((((1,1-DIMETILETIL ) AMINO) CARBONIL) AMINO) -3,3-DIMETIL-1-OXOBUTIL) -6,6-DIMETIL-3-AZABICICLO (3.1.0) HEXAN-2-CARBOXAMIDE AS INHIBITOR OF THE NS3 / NS4A SERINA PROTEASA DEL VIRUS DE HEPATITIS C | |
MY164469A (en) | Hcv ns3 protease inhibitors | |
WO2005037860A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
AR084393A1 (en) | METHODS TO TREAT HEPATITIS C VIRUS, COMPOSITION, USE, COMBINATION, KIT AND ONE OR MORE ANTI HCV COMPOUNDS | |
NZ599284A (en) | Combinations of a specific hcv ns5a inhibitor and an hcv ns3 protease inhibitor | |
TW200510391A (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
WO2008002924A3 (en) | Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors | |
WO2008106058A3 (en) | Inhibitors of serine proteases | |
PE20090228A1 (en) | SULFUR COMPOUNDS AS INHIBITORS OF HEPATITIS C VIRUS SERINE PROTEASE NS3 | |
WO2004113365A3 (en) | Hepatitis c serine protease tri-peptide inhibitors | |
BRPI0415935A (en) | hcv treatment combinations | |
MX2010006210A (en) | Fluorinated tripeptide hcv serine protease inhibitors. | |
WO2009053828A3 (en) | P3 hydroxyamino macrocyclic hepatitis c serine protease inhibitors | |
JP2014504643A5 (en) | ||
NZ592705A (en) | 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication | |
GEP20247600B (en) | B-D-2'-DEOXY-2'a-FLUORO-2'-B-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT | |
UA95715C2 (en) | Phosphadiazine derivatives, pharmaceutical composition and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ERR | Error or correction |
Free format text: THE MISSING INVENTOR HAS BEEN ADDED (1302054, TAYLOR, JAMES; 1415831, TSE, WINSTON, C.; 1415834, SCHROEDER, SCOTT, D.; 3049364, VIVIAN, RANDALL, W., 1430 VIA VISTASAN MATEO, CA 94404, US; 3074143, COTTELL, JEROMY J., 701 BALTIC CIRCLE, #719, REDWOOD CITY, CALIFORNIA 94065, US; 3074160, LINK, JOHN O., 74 PROSPECT AVENUE, SAN FRANCISCO, CALIFORNIA 94110, US; 3074170, YANG, ZHENG-YU, 338 EL CARMELO AVENUE, PALO ALTO, CALIFORNIA 94306, US) Effective date: 20140117 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 26 JUN 2015 BY AJ PARK Effective date: 20140613 |
|
LAPS | Patent lapsed |